Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Midsona - Margins over matter

24 april 2026

<a id="bm-comp-459e944e-4137-4fc9-a7cf-86d22e0b8e40" name="bm-comp-459e944e-4137-4fc9-a7cf-86d22e0b8e40" class="BMCustomAnchor"></a><table><tr><td bm-component-id="459e944e-4137-4fc9-a7cf-86d22e0b8e40" style="vertical-align: top; width:100.000000%;"><ul><li>Adj. EBIT well above estimates at SEK 45m</li><li>Underlying performance strong, but keep an eye out for ME conflict</li><li>Consensus adj. EBIT revisions likely up low-single-digits</li></ul></td></tr></table><a id="bm-comp-a05b8969-c284-4fba-abd2-f4c19a18094b" name="bm-comp-a05b8969-c284-4fba-abd2-f4c19a18094b" class="BMCustomAnchor"></a><table><tr><td bm-component-id="a05b8969-c284-4fba-abd2-f4c19a18094b" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">A beat where it matters</h3><p>The Q1 report was slightly softer than expected on sales, but more importantly well above our earnings estimates. Sales amounted to SEK 893m (-2% vs ABGSC 909m), for an organic growth of -1.3% (-1.7pp vs ABGSC 0.4%). The sales drag came primarily from contract manufacturing (-1.9% organic) due to terminated contracts post the Spain fire, and licensed brands (-2.2%). Own consumer brands were roughly flat organically (0.1%), with organic food doing well but health foods and consumer health lagging (partly a timing issue as Swedish grocery trade shifted its launch window from Q1 to Q2). On earnings, both the gross margin and adj. EBIT margin came in above our expectations (~1pp higher, respectively), driven partly by product mix and the now fully implemented cost savings programme. Adj. EBIT came in at SEK 45m (19% vs ABGSC 38m), for a margin of 5.0% (ABGSC 4.2%). The NRI of SEK 56m is a previously announced insurance compensation. Free cash flow (ex. M&amp;A) came in at SEK 32m (vs. ABGSCe 43m), and was positively affected by the insurance payment. However, this was offset by inventory build-up related Middle East supply uncertainty, Q2 launch preparations, and a notable spike in receivables from late March invoicing/payment timing. The WC build-up should normalise in Q2.</p><h3 class="bm-h3">Green shoots, one cloud on the horizon</h3><p>We are encouraged to see South Europe return to profitability (SEK 3m vs. 0m Q1'25). Moreover, the softness in the Nordics is expected to reverse in Q2, due to the shifted launch window within Swedish health/consumer. Still no news on whether Midsona will rebuild the Spanish factory, but a decision will be made in H1'26. We are also excited about Q2 due to the Risenta acquisition. On a less positive note, management flags potential cost headwinds in H2'26 due to volatile energy and transport costs (with potential raw material pass-through effects), due to current geopolitical events. At this time, we do not interpret this risk as immediate or material, but the longevity and development of the ME conflict is something to look out for.</p><h3 class="bm-h3">Likely positive consensus EBIT estimate revisions</h3><p>The share, which has been strong into numbers, is trading at ~10x-7x '26e-'28e EV/EBITA on our unrevised estimates. Our initial understanding of the report as well as a mechanical calculation suggest that consensus' adj. EBIT estimates for '26e-'28e could be positive within a mid-single-digit range. However, the beat might be partly offset on a FY basis, on caution due to potential raw material headwinds. The company will host a presentation of the Q1 report at CET 11.00 (<a data-bm-trackable="false" href="https://midsona.events.inderes.com/q1-report-2026/register" target="_blank">link</a>).</p><table id="bm-img-488fa738-0198-4f8a-a16e-eafd3f80d8d3" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation table</td></tr><tr><td><img bm-img-encrypt="488fa738-0198-4f8a-a16e-eafd3f80d8d3" bm-img-original-height="409" bm-img-original-width="567" bm-img-svg="image:image_upload/95617_7e8e413d-a566-4557-a5d0-d0ff38b00e7b.svg" bm-img-width-hint="77.99%" id="bm-id-488fa738-0198-4f8a-a16e-eafd3f80d8d3" src="https://abgsc.bluematrix.com/images/image_upload/95617_7e8e413d-a566-4557-a5d0-d0ff38b00e7b_567.png" svg="/nas/web/clients/abgsc/images/image_upload/95617_7e8e413d-a566-4557-a5d0-d0ff38b00e7b.svg" width="567" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, company data</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-04-29 StrongPoint - EBITDA beat on stronger gross margin StrongPoint Analys
2026-04-28 Alligo - Positive trend continues Alligo Analys
2026-04-28 Ovzon - More orders incoming Ovzon Analys
2026-04-28 Ework Group - Still operating a weak market Ework Group Analys
2026-04-28 CTT Systems - Solid Q1, softer Q2, improving H2'26 CTT Systems Analys
2026-04-26 Nilörn - Bruised but not broken Nilörn Analys
2026-04-26 Midsona - Growth lagging but execution improving Midsona Analys
2026-04-24 Cavotec - Strong orders mask a soft quarter Cavotec Analys
2026-04-24 Eltel - Small quarter, but y-o-y trend should con... Eltel Analys
2026-04-24 Alligo - Harsh winter drives strong organic growth Alligo Analys
2026-04-24 Nilörn - Currency and timing do the damage Nilörn Analys
2026-04-24 Midsona - Margins over matter Midsona Analys
2026-04-24 Cavotec - Orders strong, miss on sales & earnings Cavotec Analys
2026-04-23 Prevas - Through the soft patch Prevas Analys
2026-04-23 Careium - Relief around the corner Careium Analys
2026-04-23 Svedbergs Group - Looking forward to the move Svedbergs G.. Analys
2026-04-23 Studsvik - Building on nuclear tailwinds Studsvik Analys
2026-04-23 Ovzon - US holds more potential Ovzon Analys
2026-04-23 Studsvik - Segments in line, corporate costs drag... Studsvik Analys
2026-04-23 Careium - Strong growth makes up for elevated costs Careium Analys